枯草芽孢杆菌嘌呤合成途径的修饰对腺苷积累的影响

【目的】研究嘌呤操纵子中purF、purM、purN、purH和purD基因的共同过表达对枯草芽孢杆菌发酵生产腺苷的影响。【方法】利用温敏质粒pKS1,以单交换的形式增加了purF基因在基因组上的拷贝数,同时将强启动子P43插入嘌呤操纵子中,使嘌呤合成途径中purF基因及其下游purM、purN、purH和purD基因的表达水平得到加强,通过实时定量PCR(Realtime Quantitative PCR,RT-qPCR)测定相关基因(purF、purM、purN、purH和purD)的转录水平;通过酶活性检测分析关键酶基因扩增对PRPP转酰胺酶活性的影响;通过发酵实验考察出发菌株与工程菌株的生长、耗糖和腺苷积累情况。【结果】实时定量PCR结果表明,purF、purM、purN、purH和purD基因的表达水平均有不同程度的提高,嘌呤合成途径中关键酶PRPP转酰胺酶的活性是出发菌株的2.4倍。摇瓶发酵实验发现工程菌腺苷产量较出发菌提高17.5%,糖苷转化率增加26.1%。5 L罐发酵实验表明,虽然工程菌的菌体生长受到一定的影响,但在相同发酵周期内腺苷产量比出发菌提高了9.7%。【结论】嘌呤操纵子中purF、purM、purN、purH和purD基因转录水平的增强能够提高腺苷的产量,为通过代谢工程技术改造腺苷生产菌提供了理论依据和研究思路。     

枯草芽孢杆菌基因修饰生产核黄素

【目的】研究枯草芽孢杆菌核黄素合成途径、木糖代谢相关基因修饰对核黄素合成的影响。【方法】单独过表达或共同过表达核黄素操纵子中的基因、过表达木糖代谢相关基因构建相应的重组菌株。通过测定和比较重组菌株摇瓶发酵的核黄素产量和生物量,表征各个基因修饰的效应。采用摇瓶和5 L罐发酵,考察木糖作为主要碳源以及木糖与蔗糖共代谢对核黄素发酵的影响。【结果】ribA基因单独过表达,使核黄素产量提高99%,但生物量降低30%,出现细胞自溶现象。ribA-ribH基因共表达,使核黄素产量提高280%,并且无细胞自溶和生物量下降现象。1.5%蔗糖与6.5%木糖作为碳源,5 L发酵罐发酵70 h,核黄素产量达到3.6 g/L,与8%蔗糖为碳源的发酵相比,核黄素产量提高80%。木糖代谢相关基因过表达,均明显降低核黄素产量。【结论】与ribA基因单独过表达相比,ribA-ribH基因共表达可有效避免细胞自溶现象,并能进一步提高核黄素产量。蔗糖与木糖共代谢,能够改善前体物供给,有利于提高核黄素产量。     

过表达TatAdCd转位酶对枯草芽孢杆菌脂肪酶分泌的影响

【目的】研究过表达枯草芽孢杆菌Tat运输途径的Tat Ad Cd转位酶对促进脂肪酶分泌的影响。【方法】用cdd基因的串联启动子和前导区,替换tat AD-CD操纵子的启动子和前导区,并在染色体sac B基因位点整合表达;采用q RT-PCR方法表征tat AD-CD操纵子的表达水平;用脂肪酶表达质粒p HP13L转化Tat Ad Cd转位酶过表达菌株,构建产脂肪酶重组菌。通过测定脂肪酶活性,以及聚丙烯酰胺凝胶电泳,考察Tat Ad Cd转位酶过表达对脂肪酶分泌的影响。【结果】tat AD-CD操纵子被过表达,其胞内m RNA相对水平提高了185倍。Tat Ad Cd转位酶的过表达,使脂肪酶发酵单位提高了40%。【结论】使用cdd基因的串联启动子和前导区,能够有效地过表达目的基因;枯草芽孢杆菌脂肪酶可以同时经由Sec途径和Tat途径分泌;过表达Tat Ad Cd转位酶,能够显著提高脂肪酶的分泌量。     

关键基因的修饰对枯草芽孢杆菌尿苷合成的影响

【目的】探究磷酸核糖焦磷酸(PRPP)合成酶(prs)和氨甲酰磷酸合成酶(pyr AA/pyr AB)的点突变,以及异源5′-核苷酸酶(sdt1)的过表达,对枯草芽孢杆菌尿苷生物合成的影响。【方法】依据推断的变构位点,分别在prs基因和pyr AB基因编码序列中引入点突变;将点突变的prs基因在染色体xyl R位点整合表达,pyr AB基因则在染色体原位被修饰;sdt1基因在染色体sac B位点整合过表达。通过对重组菌摇瓶发酵液中尿苷、胞苷和尿嘧啶的分析,表征相关基因修饰对尿苷合成的影响。【结果】在PRPP合成酶中引入Asn120Ser、Leu135Ile和Glu52Gly或Val312Ala点突变,分别导致尿苷积累量提高67%和96%。进一步在氨甲酰磷酸合成酶中引入Ser948Phe、Thr977Ala和Lys993Ile点突变,导致尿苷积累量又增加了182%,达到6.97 g/L。在此基础上,过表达异源5′-核苷酸酶,导致尿苷产量增加17%,达到8.16 g/L。【结论】PRPP合成酶和氨甲酰磷酸合成酶的酶活或反馈抑制调节机制,是限制尿苷过量合成的重要因素。PRPP合成酶的Asn120Ser和Leu135Ile点突变,以及氨甲酰磷酸合成酶的Ser948Phe、Thr977Ala和Lys993Ile点突变,能够显著促进尿苷合成。PRPP合成酶附加的Glu52Gly或Val312Ala点突变,有利于尿苷合成。异源的嘧啶专一性5′-核苷酸酶的引入,也对尿苷的合成有明显的促进作用。     

假单胞菌M18中藤黄绿菌素合成限速酶基因的鉴定及表达优化

【目的】假单胞菌株M18中负责抗真菌剂藤黄绿菌素(Plt)合成的结构基因包括pltLABCDEFG、pltM。为了鉴定Plt合成限速酶的基因,分别将9个结构基因过表达。【方法】以M18菌株染色体DNA为模板,PCR扩增这9个Plt合成基因的编码区,分别克隆到穿梭载体pME6032的tac启动子下游,构建9个结构基因的过表达载体,并转入假单胞菌株M18中。在KMB培养基中进行Plt发酵分析。【结果】分别携带pltC、pltD、pltF过表达载体的菌株与携带空质粒的菌株相比,Plt产量分别提高了96%、78%、75%。对重组菌株进行IPTG诱导浓度和诱导时间的优化,确定IPTG最佳诱导浓度为1.0 mmol/L,最佳诱导时间为培养6 h。【结论】pltC、pltD、pltF分别编码的Ⅰ型聚酮合成酶、卤化酶、乙酰CoA合成酶可能为Plt生物合成的限速酶。按照优化条件发酵,携带pltD、pltF过表达质粒的菌株产量分别上升77.5%、159.1%。     

肌苷和鸟苷生产菌中嘌呤核苷合成途径三段基因序列的分析

为了研究肌苷和鸟苷生产菌中与产苷有关的嘌呤核苷合成途径的遗传背景,选择了pur操纵子的启动子序列、编码SAMP合成酶的purA基因和编码GMP合成酶的guaA基因,设计合适的引物,分别从野生菌、一株肌苷低产菌和肌苷鸟苷高产菌中扩增出相应片段,经克隆和测序后,对它们进行比较和分析。分析结果表明两株生产菌的purA基因发生了1个碱基缺失,导致阅读框发生移码突变;而鸟苷高产菌在pur操纵子的启动子部分和操纵子抑制蛋白结合区域发生了近10％的突变,可能影响整个操纵子的表达调控。     

含苏氨酸操纵子重组质粒的构建及其对大肠杆菌L-苏氨酸积累的影响

摘要：【目的】通过分子生物学手段构建重组质粒,将其转入野生型大肠杆菌W3110,分析含苏氨酸操纵子基因的质粒及质粒定点突变解除反馈抑制时,对L-苏氨酸积累的影响。【方法】以W3110染色体DNA为模板,PCR扩增苏氨酸操纵子基因,即启动子THrLp、编码前导肽基因thrL以及thrA、thrB、thrC基因,通过重叠延伸PCR的方法对thrA基因定点突变,解除苏氨酸对它的反馈抑制,构建出重组表达质粒WYE112和WYE134,5 L发酵实验测定L-苏氨酸的产量。【结果】经5 L发酵罐发酵产酸实验,W3110的L-苏氨酸产量为0.036 ± 0.004 g/L,携带含苏氨酸操纵子质粒的W3110菌株L-苏氨酸产量为2.590 ± 0.115 g/L,质粒上thrA解除反馈抑制后,L-苏氨酸的产量增加到9.223 ± 1.279 g/L。【结论】过表达苏氨酸操纵子基因可以使L-苏氨酸积累,进一步解除thrA基因的反馈抑制,可以增强L-苏氨酸积累的效果,为L-苏氨酸工程菌改造的进一步研究奠定了基础。     

过表达腺苷生物合成正相关基因GlPNP提高灵芝腺苷的含量

【背景】灵芝被纳入我国“药食同源”试点名单，腺苷作为其主要活性物质之一，在免疫调节、抗炎、抗癌等方面发挥着重要作用。【目的】调控腺苷生物合成关键酶基因的表达来提高灵芝腺苷产量。【方法】将不同培养时间阶段腺苷合成酶基因(包括5-氨基咪唑-4-甲酰胺核糖核苷酸甲酰转移酶GlATIC、嘌呤核苷磷酸化酶GlPNP、腺苷激酶GlADK)的表达量与腺苷含量相关联，筛选出与灵芝腺苷含量呈正相关的关键酶基因。克隆关键酶基因并在灵芝中过表达，探究关键酶基因过表达对灵芝腺苷积累的影响。【结果】GlPNP的表达与灵芝腺苷含量呈正相关。GlPNP的cDNA全长为969 bp，预测GlPNP蛋白的相对分子量为34.6 kDa，呈三聚体的四元结构。研究结果表明，过表达菌株中GlPNP的表达量在第4天比野生型菌株(WT)上调了2.9-3.9倍，与含空载体的菌株(CK)相比，腺苷含量分别提高了78%和63%。【结论】过表达嘌呤核苷磷酸化酶是提高灵芝腺苷产量的一种有效手段。     

鼠疫菌H-NS蛋白的表达与纯化及其DNA结合活性

摘要：【目的】利用大肠杆菌BL21λDE3的表达系统,表达出有活性的鼠疫耶尔森氏菌（以下简称鼠疫菌）调控子蛋白H-NS,为进一步研究H-NS的转录调控奠定基础。【方法】 PCR扩增鼠疫菌201株hns基因的编码区,将其直接克隆入pET28a质粒中,再将pET28a-hns重组质粒转入大肠杆菌BL21λDE3菌株中,所得菌株经IPTG诱导后能表达出鼠疫菌His-H-NS蛋白;通过体外的凝胶迁移实验（EMSA）和DNaseⅠ足迹实验对His-H-NS蛋白与DNA的结合活性进行分析。【结果】成功表达出有活性的鼠疫菌His-H-NS蛋白,该蛋白对鼠疫菌pH6抗原基因（psaA、psaE）及rovA基因均有结合活性。【结论】鼠疫菌His-H-NS具有DNA结合活性,说明H-NS能调控鼠疫菌基因的转录。     

绿针假单胞菌GP72中aurI/aurR系统调控功能

【背景】绿针假单胞菌(Pseudomonas chlororaphis) GP72是一株可生产吩嗪类抗生素吩嗪-1-羧酸(PCA)和2-羟基吩嗪(2-OH-PHZ)的生防根际促生菌。基因组比对发现GP72菌中存在aurI/aurR双元调控系统。【目的】研究该系统对GP72中吩嗪类物质的调控作用。【方法】将aurI基因在大肠杆菌中异源表达,用紫色杆菌CV026和根癌农杆菌NTL4做显色实验。构建基因敲除菌株和回补菌株,发酵测量突变株的生长曲线与总吩嗪产量。构建转录融合质粒,测定吩嗪合成基因启动子的转录水平。【结果】显色实验显示,aurI能产生多种信号分子,使CV026显紫色、NTL4显蓝色。分别单独敲除aurI和aurR基因,同时敲除aurI/aurR基因,吩嗪产量均会升高,而回补菌株吩嗪产量降为野生型水平。β-半乳糖苷酶活性测定结果显示,突变株的酶活比野生型高。【结论】aurI/aurR负调控GP72的吩嗪合成,通过抑制吩嗪合成启动子的转录而影响吩嗪类物质的产量。     

gsk disruption leads to guanosine accumulation in Escherichia coli.

We tried some improvement of inosine production using an inosine-producing mutant of Escherichia coli which is deficient in purF (phosphoribosylpyrophosphate (PRPP) amidotransferase gene), purA (succinyl-adenosine 5'-monophosphate (AMP) synthetase gene), deoD (purine nucleoside phosphorylase gene), purR (purine repressor gene) and add (adenosine deaminase gene), and harboring the desensitized PRPP amidotransferase gene as a plasmid. The guaB (inosine 5'-monophosphate (IMP) dehydrogenase gene) disruption brought about a slightly positive effect on the inosine productivity. Alternatively, the gsk (guanosine-inosine kinase gene) disruption caused a considerable amount of guanosine accumulation together with a slight increase in the inosine productivity. The further addition of guaC (guanosine 5'-monophosphate (GMP) reductase gene) disruption did not lead to an increased guanosine accumulation, but brought about the decrease of inosine accumulation.     

Investigation of various genotype characteristics for inosine accumulation in Escherichia coli W3110

For the derivation of an inosine-overproducing strain from the wild type microorganism, it is known that the addition of an adenine requirement, removal of purine nucleoside hydrolyzing activity, removal of the feedback inhibition, and repression of key enzymes in the purine nucleotides biosynthetic pathway are essential. Thus, the disruption of purA (adenine requirement), deoD (removal of purine nucleosides phosphorylase activity), purR (derepression of the regulation of purine nucleotides biosynthetic pathway), and the insensitivity of the feedback inhibition of phosphoribosylpyrophosphate (PRPP) amidotransferase by adenosine 5'-monophosphate (AMP) and guanosine 5'-monophosphate (GMP) were done in the Escherichia coli strain W3110, and then the inosine productivity was estimated. In the case of using a plasmid harboring the PRPP amidotransferase gene (purF) that encoded a desensitized PRPP amidotransferase, purF disrupted mutants were used as the host strains. It was found that the innovation of the four genotypes brought about a small amount of inosine accumulation. Furthermore, an adenine auxotrophic mutant of E. coli showed inappropriate adenine use because its growth could not respond efficiently to the concentration of adenine added. As the presence of adenosine deaminase is well known in E. coli and it is thought to be involved in adenine use, a mutant disrupted adenosine deaminase gene (add) was constructed and tested. The mutant, which is deficient in purF, purA, deoD, purR, and add genes, and harboring the desensitized purF as a plasmid, accumulated about 1 g of inosine per liter. Although we investigated the effects of purR disruption and purF gene improvement, unexpectedly an increase in the inosine productivity could not be found with this mutant.     

Complete genome sequence of Bacillus amyloliquefaciens TA208, a strain for industrial production of guanosine and ribavirin

Here, we report the complete genome sequence of Bacillus amyloliquefaciens TA208, a strain for industrial production of guanosine and synthesis of ribavirin by assimilation of formamide. Comparison of its genome sequence with those of strains DSM7 and FZB42 revealed horizontal gene transfer represented by unique prophages and restriction-modification systems and indicated significant accumulation of guanosine.     

Role of guanosine kinase in the utilization of guanosine for nucleotide synthesis in Escherichia coli

Using purine auxotrophic strains of Escherichia coli with additional genetic lesions in the pathways of interconversion and salvage of purine compounds, we demonstrated the in vivo function of guanosine kinase and inosine kinase. Mutants with increased ability to utilize guanosine were isolated by plating cells on medium with guanosine as the sole purine source. These mutants had altered guanosine kinase activity and the mutations were mapped in the gene encoding guanosine kinase, gsk. Some of the mutants had acquired an additional genetic lesion in the purine de novo biosynthetic pathway, namely a purF, a purL or a purM mutation. A revised map location of the gsk gene is presented and the gene order established as proC-acrA-apt-adk-gsk-purE.     

Utilization of 2,6-diaminopurine by Salmonella typhimurium

The pathway for the utilization of 2,6-diaminopurine (DAP) as an exogenous purine source in Salmonella typhimurium was examined. In strains able to use DAP as a purine source, mutant derivatives lacking either purine nucleoside phosphorylase or adenosine deaminase activity lost the ability to do so. The implied pathway of DAP utilization was via its conversion to DAP ribonucleoside by purine nucleoside phosphorylase, followed by deamination to guanosine by adenosine deaminase. Guanosine can then enter the established purine salvage pathways. In the course of defining this pathway, purine auxotrophs able to utilize DAP as sole purine source were isolated and partially characterized. These mutants fell into several classes, including (i) strains that only required an exogenous source of guanine nucleotides (e.g., guaA and guaB strains); (ii) strains that had a purF genetic lesion (i.e., were defective in alpha-5-phosphoribosyl 1-pyrophosphate amidotransferase activity); and (iii) strains that had constitutive levels of purine nucleoside phosphorylase. Selection among purine auxotrophs blocked in the de novo synthesis of inosine 5'-monophosphate, for efficient growth on DAP as sole source of purine nucleotides, readily yielded mutants which were defective in the regulation of their deoxyribonucleoside-catabolizing enzymes (e.g., deoR mutants).     

Orientation of the guanine operon of Escherichia coli K-12 by utilizing strains containing guaB-xse and guaB-upp deletions.

Temperature induction of an Escherichia coli strains with lambda cI1857 integrated in the guaB gene has been used to produce strains containing chromosomal deletions extending into the xse and upp genes. By utilizing strains containing these deletions, it has been possible to order the genes in the guanine operon with respect to the xseA and upp genes. The order of the genes in this region is glyA-hisS-xseA-guaO-guaB-guaA-purG-upp-purC.     

Modulation of guanosine nucleotides biosynthetic pathways enhanced GDP-<Emphasis Type="SmallCaps">l</Emphasis>-fucose production in recombinant <Emphasis Type="Italic">Escherichia coli</Emphasis>

Guanosine 5′-triphosphate (GTP) is the key substrate for biosynthesis of guanosine 5′-diphosphate (GDP)-l-fucose. In this study, improvement of GDP-l-fucose production was attempted by manipulating the biosynthetic pathway for guanosine nucleotides in recombinant Escherichia coli-producing GDP-l-fucose. The effects of overexpression of inosine 5′-monophosphate (IMP) dehydrogenase, guanosine 5′-monophosphate (GMP) synthetase (GuaB and GuaA), GMP reductase (GuaC) and guanosine–inosine kinase (Gsk) on GDP-l-fucose production were investigated in a series of fed-batch fermentations. Among the enzymes tested, overexpression of Gsk led to a significant improvement of GDP-l-fucose production. Maximum GDP-l-fucose concentration of 305.5 ± 5.3 mg l⁻¹ was obtained in the pH-stat fed-batch fermentation of recombinant E. coli-overexpressing Gsk, which corresponds to a 58% enhancement in the GDP-l-fucose production compared with the control strain overexpressing GDP-l-fucose biosynthetic enzymes. Such an enhancement of GDP-l-fucose production could be due to the increase in the intracellular level of GMP.